人保稱權益投資差異化監管提供更大空間
內媒報道,人保(01339.HK)舉行中期業績發布會,人保資產副總裁黃本堯表示,近期銀保監會對保險機構權益配置實施差異化的監管,實際上是對於資本實力比較充足、經營穩健、資產負債管理情況比較好的保險公司,拓寬了權益類資產的配置的空間,也為未來獲取權益類投資更多的收益,提供了更好的機會。
他指,目前人保的綜合償付能力充足率保持高水平,差異化政策對人保未來在權益資產的運作提供了非常大的空間。人保財險按照監管的政策實際上權益投資上限可以到40%,人保壽險上限可以到35%,都比以前有所提升。現在正在積極地研究論證政策的變動,對未來權益資產的戰略配置中樞比例的影響,以及進一步優化全年資產配置上限的約束條件。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.